W
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Withus Pharmaceutical Co Ltd
KOSDAQ:330350
Price:
9 850
KRW
-6.64%
Market Closed
Market Cap:
₩130B
Income Statement
Earnings Waterfall
Withus Pharmaceutical Co Ltd
Withus Pharmaceutical Co Ltd
Income Statement
Withus Pharmaceutical Co Ltd
Withus Pharmaceutical Co Ltd
Currency: KRW
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
148
|
140
|
221
|
310
|
324
|
332
|
360
|
382
|
391
|
353
|
408
|
484
|
596
|
747
|
784
|
804
|
814
|
812
|
789
|
0
|
|
| Revenue |
53 743
N/A
|
52 393
-3%
|
65 271
+25%
|
26 216
-60%
|
53 862
+105%
|
54 148
+1%
|
56 105
+4%
|
57 419
+2%
|
61 564
+7%
|
62 461
+1%
|
64 618
+3%
|
64 680
+0%
|
63 032
-3%
|
65 794
+4%
|
68 975
+5%
|
80 119
+16%
|
90 147
+13%
|
98 274
+9%
|
105 739
+8%
|
102 722
-3%
|
102 506
0%
|
102 494
0%
|
102 107
0%
|
|
| Gross Profit | ||||||||||||||||||||||||
| Cost of Revenue |
(19 379)
|
(19 426)
|
(24 567)
|
(11 067)
|
(21 083)
|
(22 157)
|
(23 164)
|
(23 894)
|
(26 175)
|
(25 794)
|
(26 406)
|
(26 345)
|
(25 503)
|
(26 717)
|
(27 893)
|
(31 481)
|
(34 091)
|
(36 121)
|
(38 339)
|
(37 168)
|
(36 966)
|
(37 374)
|
(36 749)
|
|
| Gross Profit |
34 365
N/A
|
32 967
-4%
|
40 703
+23%
|
15 150
-63%
|
32 776
+116%
|
31 989
-2%
|
32 939
+3%
|
33 525
+2%
|
35 390
+6%
|
36 667
+4%
|
38 212
+4%
|
38 335
+0%
|
37 529
-2%
|
39 077
+4%
|
41 082
+5%
|
48 638
+18%
|
56 056
+15%
|
62 153
+11%
|
67 400
+8%
|
65 554
-3%
|
65 540
0%
|
65 120
-1%
|
65 358
+0%
|
|
| Operating Income | ||||||||||||||||||||||||
| Operating Expenses |
(23 607)
|
(23 232)
|
(30 347)
|
(13 787)
|
(26 778)
|
(28 311)
|
(28 125)
|
(28 639)
|
(29 336)
|
(30 095)
|
(31 107)
|
(33 457)
|
(34 637)
|
(35 849)
|
(37 818)
|
(40 729)
|
(46 064)
|
(53 512)
|
(59 075)
|
(59 893)
|
(60 907)
|
(59 840)
|
(60 718)
|
|
| Selling, General & Administrative |
(23 606)
|
(21 386)
|
(29 623)
|
(12 734)
|
(25 264)
|
(26 200)
|
(26 234)
|
(26 624)
|
(27 048)
|
(27 426)
|
(28 086)
|
(30 128)
|
(30 998)
|
(32 334)
|
(34 603)
|
(37 534)
|
(43 105)
|
(49 928)
|
(55 288)
|
(56 026)
|
(56 711)
|
(56 431)
|
(56 300)
|
|
| Research & Development |
0
|
(1 512)
|
(632)
|
(856)
|
(1 214)
|
(1 666)
|
(1 374)
|
(1 420)
|
(1 586)
|
(1 852)
|
(2 108)
|
(2 357)
|
(2 615)
|
(2 410)
|
(2 067)
|
(1 868)
|
(1 517)
|
(2 084)
|
(2 192)
|
(2 297)
|
(2 404)
|
(1 600)
|
(2 561)
|
|
| Depreciation & Amortization |
0
|
(333)
|
(91)
|
(197)
|
(300)
|
(444)
|
(517)
|
(595)
|
(702)
|
(817)
|
(913)
|
(973)
|
(1 024)
|
(1 105)
|
(1 148)
|
(1 327)
|
(1 443)
|
(1 501)
|
(1 595)
|
(1 570)
|
(1 587)
|
(1 603)
|
(1 652)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(205)
|
(205)
|
(205)
|
|
| Operating Income |
10 758
N/A
|
9 735
-10%
|
10 357
+6%
|
1 362
-87%
|
5 999
+340%
|
3 679
-39%
|
4 815
+31%
|
4 886
+1%
|
6 054
+24%
|
6 572
+9%
|
7 105
+8%
|
4 878
-31%
|
2 892
-41%
|
3 229
+12%
|
3 264
+1%
|
7 909
+142%
|
9 992
+26%
|
8 641
-14%
|
8 325
-4%
|
5 661
-32%
|
4 634
-18%
|
5 280
+14%
|
4 640
-12%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||
| Interest Income Expense |
560
|
554
|
759
|
537
|
988
|
884
|
703
|
1 044
|
869
|
661
|
847
|
(295)
|
(101)
|
11
|
1 180
|
1 648
|
1 062
|
574
|
(361)
|
(464)
|
(486)
|
765
|
480
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(205)
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
5
|
5
|
0
|
0
|
(385)
|
(385)
|
(379)
|
(374)
|
11
|
11
|
6
|
4
|
9
|
9
|
7
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(265)
|
(253)
|
(264)
|
(2)
|
(58)
|
(151)
|
(232)
|
(305)
|
(248)
|
(331)
|
(278)
|
(435)
|
(524)
|
(354)
|
(533)
|
(426)
|
(440)
|
(571)
|
(522)
|
148
|
504
|
509
|
1 774
|
|
| Pre-Tax Income |
11 052
N/A
|
10 036
-9%
|
10 857
+8%
|
1 902
-82%
|
6 929
+264%
|
4 413
-36%
|
4 900
+11%
|
5 240
+7%
|
6 296
+20%
|
6 528
+4%
|
7 685
+18%
|
4 158
-46%
|
2 273
-45%
|
2 891
+27%
|
3 920
+36%
|
9 141
+133%
|
10 621
+16%
|
8 649
-19%
|
7 442
-14%
|
5 139
-31%
|
4 652
-9%
|
6 554
+41%
|
6 894
+5%
|
|
| Net Income | ||||||||||||||||||||||||
| Tax Provision |
(2 309)
|
(1 997)
|
(2 106)
|
(35)
|
(924)
|
(636)
|
(846)
|
(976)
|
(1 207)
|
(1 246)
|
(2 261)
|
(1 679)
|
(1 216)
|
(1 285)
|
(656)
|
(1 182)
|
(1 427)
|
(997)
|
(717)
|
(354)
|
(240)
|
(574)
|
(632)
|
|
| Income from Continuing Operations |
8 743
|
8 039
|
8 751
|
1 867
|
6 006
|
3 778
|
4 056
|
4 264
|
5 089
|
5 282
|
5 424
|
2 479
|
1 057
|
1 606
|
3 264
|
7 959
|
9 194
|
7 652
|
6 725
|
4 785
|
4 412
|
5 980
|
6 262
|
|
| Net Income (Common) |
8 743
N/A
|
8 039
-8%
|
8 751
+9%
|
1 867
-79%
|
6 006
+222%
|
3 778
-37%
|
4 056
+7%
|
4 264
+5%
|
5 089
+19%
|
5 282
+4%
|
5 424
+3%
|
2 479
-54%
|
1 057
-57%
|
1 606
+52%
|
3 264
+103%
|
7 959
+144%
|
9 194
+16%
|
7 652
-17%
|
6 725
-12%
|
4 785
-29%
|
4 412
-8%
|
5 980
+36%
|
6 262
+5%
|
|
| EPS (Diluted) |
1 092.83
N/A
|
1 004.87
-8%
|
972.29
-3%
|
207.44
-79%
|
455.41
+120%
|
286.44
-37%
|
307.57
+7%
|
323.32
+5%
|
385.92
+19%
|
400.44
+4%
|
411.19
+3%
|
187.97
-54%
|
79.51
-58%
|
121.34
+53%
|
247.45
+104%
|
603.41
+144%
|
696.63
+15%
|
590.98
-15%
|
509.48
-14%
|
362.49
-29%
|
334.26
-8%
|
453.04
+36%
|
474.39
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
